Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.9M
-
Number of holders
-
196
-
Total 13F shares, excl. options
-
37.9M
-
Shares change
-
-42.2K
-
Total reported value, excl. options
-
$3.36B
-
Value change
-
-$15.2M
-
Put/Call ratio
-
0.7
-
Number of buys
-
96
-
Number of sells
-
-110
-
Price
-
$88.66
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q4 2014
242 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q4 2014.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 196 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.9M shares
of 44.9M outstanding shares and own 84.45% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (4.38M shares), FMR LLC (3.19M shares), GILDER GAGNON HOWE & CO LLC (3.03M shares), JENNISON ASSOCIATES LLC (2.86M shares), VANGUARD GROUP INC (2.13M shares), MARSICO CAPITAL MANAGEMENT LLC (1.68M shares), BlackRock Fund Advisors (1.53M shares), JANUS CAPITAL MANAGEMENT LLC (1.15M shares), State Street Corp (1.04M shares), and BlackRock Institutional Trust Company, N.A. (928K shares).
This table shows the top 196 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.